アンメットニーズである「がん性貧血」の新規治療法開発

• Project/Area Number: 25K22582
• Research Category: Grant-in-Aid for Challenging Research (Exploratory)
• Allocation Type: Multi-year Fund
• Review Section: Medium-sized Section 50:Oncology and related fields
• Research Institution: Tokyo University of Pharmacy and Life Science
• Principal Investigator: 原田 浩徳 東京薬科大学, 生命科学部, 教授 (10314775)
• Project Period (FY): 2025-06-27 – 2027-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000); Fiscal Year 2026: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000); Fiscal Year 2025: ¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)